New Caledonia vs Palau: Tuberculosis patients who tested positive for HIV
New Caledonia
0 patients
in 2021
Palau
0 patients
in 2021
New Caledonia rank
160th
Palau rank
160th
Tuberculosis patients who tested positive for HIV over time
- New Caledonia
- Palau
How they compare
New Caledonia currently reports 0 patients against 0 patients in Palau, a difference of 0 patients.
The two have swapped places 2 times across 8 shared years of data; in 2003 it was Palau ahead.
New Caledonia ranks 160th and Palau ranks 160th of 201 countries.
New Caledonia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | New Caledonia | Palau | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.1667 patients | 0 patients | 0.1667 patients | New Caledonia |
| 2010s | 0 patients | 0 patients | 0 patients | — |
| 2020s | 0 patients | 0 patients | 0 patients | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients who tested positive for hiv, New Caledonia or Palau?
- New Caledonia, at 0 patients against 0 patients in Palau as of 2021.
- What is the difference in tuberculosis patients who tested positive for hiv between New Caledonia and Palau?
- 0 patients, with New Caledonia ahead.
- How many years of comparable data are there for New Caledonia and Palau?
- 8 years are reported by both, from 2003 to 2021.
- How do New Caledonia and Palau rank globally for tuberculosis patients who tested positive for hiv?
- New Caledonia ranks 160th and Palau ranks 160th of 201 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients who tested positive for HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of tuberculosis (new and relapsed) patients that tested positive for HIV.